As we reflect on the six-year anniversary of the Covid-19 pandemic's arrival in Bangladesh, a critical question arises: Have we truly learned from this unprecedented global crisis?
The pandemic's impact was far-reaching, leaving an indelible mark on healthcare systems worldwide. In Bangladesh, the initial response was one of rapid adaptation, with hospitals expanding their intensive care capacity and strengthening oxygen supply systems. Vaccination campaigns eventually reached millions, but the process was not without controversy.
A Deeper Look: Institutional Resilience
While these emergency measures demonstrated a certain level of mobilization, the true test lies in the years that follow. Have the adaptations made during the pandemic become permanent fixtures, or have we simply returned to the status quo?
Recent studies conducted by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) paint a concerning picture. The presence of drug-resistant pathogens, such as Candida auris, in several intensive care units in Dhaka highlights ongoing vulnerabilities. This is not an isolated incident; similar disclosures of superbugs have been made in public hospitals, indicating broader weaknesses in infection control practices.
Financing the Fight: A Complex Picture
Public spending on health has gradually increased over the years, with budget allocations rising from over Tk 32,000 crore during the early pandemic period to nearly Tk 42,000 crore in the most recent fiscal cycle. However, the overall budget structure tells a different story. Health spending has remained close to five percent of the national budget for years, and as a share of GDP, it continues to fall short, sitting well below one percent.
This disparity is particularly striking when compared to sectors like defense, transportation, and major infrastructure, which receive significantly larger shares of public expenditure. While these choices are understandable given national security and economic growth concerns, the pandemic has shown that health crises can have equally profound impacts.
Hospitals: A Microcosm of Systemic Issues
Hospitals are a microcosm of the larger healthcare system, and they reflect the challenges and vulnerabilities within. Drug-resistant organisms like Candida auris tend to emerge in environments where infection control practices are inconsistent. This includes unregulated antibiotic use, poorly applied hygiene protocols, and inadequate monitoring systems.
Vulnerable patients, invasive procedures, crowded wards, and heavy antibiotic use create the perfect conditions for resistant organisms to spread. Preventing this requires robust institutional support, discipline, and oversight, which, unfortunately, have not been consistently implemented.
Surveillance and Early Warning Systems
The ability to recognize and respond to early warning signs is crucial in epidemic control. Bangladesh expanded its surveillance capacity during the pandemic, with increased testing laboratories and improved reporting systems. However, the structure remains irregular, with information flows among hospitals, laboratories, and central health authorities lacking systematic organization.
Private healthcare facilities, which treat a significant portion of patients, are not consistently integrated into national reporting structures. Environmental monitoring of emerging pathogens is also limited. The past years have taught us that sustained institutional strengthening is non-negotiable.
A Call to Action: Prioritizing Public Health Safety
The pandemic has shown us that pandemics test not just hospitals, but the entire system's preparedness, coordination, and foresight. The government must recognize public health safety as an integral part of national resilience. This requires consistent financing for
